used a hydro-alcoholic extract of Moringa to treat experimental colitis in mice, and observed downregulation of a group of secreted inflammatory factors and an increase of both colon lengths and the expression of glutathione-S-Transferase Pi 1 (GSTP1), which is a detoxifying enzyme mediated by NFE2-Related Factor 2 (NRF2) (Kim et al., 2017)
What that combined picture suggests: Bifidobacterium and Lactobacillus species have the most published functional-constipation trial data, with mixed results across strains Pooled meta-analyses show modest reductions in intestinal transit time with probiotic supplementation Specific strains commonly marketed for constipation (such as HN019) have larger negative trials alongside the smaller positive ones, so the honest reading is mixed Formal IBS guidelines remain conservative on probiotics overall, though bloating-specific endpoints show better signals WONDERBIOTICS Probiotics for Weight Management uses B420 as its named strain
Our data showed that cleaved casepase-3 and Bax were both upregulated in THJ-16T and CAL-62 cells upon treatment with AP probe-net (20 M) for 12 h (Fig
Permeation Enhancers Table 2 provides a summary of other peptides and associated oral administration formulation strategies that have advanced to clinical trials
An alternative, nonapoptotic form of programmed cell death
Clinical relevance for human gut conditions is not established